Financial intelligence for Asia's healthcare markets
Remember me:

News articles    

Sydney-based George Clinical, a global clinical research organisation, has appointed James as chief executive, replacing Glenn Kerkhof who becomes chairman.
Thomson Medical Group’s pre-tax profit for 2019 was $14.7 million, down 33% from the $22 million reported for 2018.
Ping An Healthcare and Technology Company has announced a 2019 loss of ¥746.7 million ($107.1 million), which compares to a net loss of ¥913.1 million announced for 2018.
Technology company Vakrangee has formed an alliance with vHealth by Aetna, which is owned by Aetna, a CVS Health company, to offer a combination of telemedicine services and privileged access to its nationwide network of hospitals and clinics.
GenapSys has launched its gene sequencer in the Asia-Pacific region, including in South Korea, Singapore, Japan, and the fast-growing Chinese gene sequencing market, which is currently at the epicenter of the Coronavirus outbreak.
Novaerus, an Irish company that manufactures and sells patented medical-grade, clean air solutions, has partnered with seven established distributors across China.
Start-up HiDoc is to open telehealth kiosks in the new Ola luxury condominiums being built in Singapore, enabling residents to have virtual medical consultations with doctors.
Singapore-based digital health start-up Gmedes has launched G-MEDS, a clinic app service that allows clinics to prescribe, bill, dispense and deliver routine medication to the homes and offices of patients or their carers.
Malaysia’s aspiration to push healthtech to the forefront will provide myriad opportunities to innovative domestic and foreign companies, according to analysis by GlobalData, a data and analytics company.
Novena Global Lifecare is donating up to one million masks and other medical supplies to hospitals in China including Wuhan, the epicentre of the coronavirus outbreak.

Subscribe to our news RSS feed Get the RSS for HealthInvestor Asia




The IPO market in Hong Kong is hotting up again and it looks as though 2019 is going to be as busy with biotech company floats as last year was.



HealthInvestor Asia twitter feed


HealthInvestor UK